Why is EGFR mutation testing important for patients?
- EGFR mutation testing allows the physician to prescribe the most suitable therapy for a patient with locally advanced or metastatic non-small cell lung cancer
- Clinical trials have shown that first-line advanced NSCLC patients with certain EGFR mutations derive significant benefit from gefitinib while patients without these mutations gain more benefit from standard chemotherapy
Mok 2009
Gefitinib Product Information
Next: Gefitinib therapy: Targeting EGFR
